ReviewAnnals of the rheumatic diseases2002
Treating human autoimmune disease by depleting B cells.
Review in Annals of the rheumatic diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00261118 (Phase 3), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Phase 3: Randomised Controlled Trial of Rituximab in Active Ulcerative Colitis
Who cites it
14 citing papers in PubMed.
- Rituximab in cryoglobulinemic peripheral neuropathy.Journal of neurology · 2009Trial
- CD19-targeted chimeric antigen receptor T-cell therapy in patients with concurrent B-cell Non-Hodgkin lymphoma and rheumatic autoimmune diseases: a propensity score matching study.Bone marrow transplantation · 2023Article
- The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.Annals of clinical and translational neurology · 2018Article
- Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.Orphanet journal of rare diseases · 2017Article
- Targeting B cells in treatment of autoimmunity.Current opinion in immunology · 2016Review
- Successful plasma exchange combined with rituximab therapy in aggressive APS-related cutaneous necrosis.Clinical rheumatology · 2013Article
- Therapeutic apheresis in autoimmune diseases.Open access rheumatology : research and reviews · 2013Review
- The role of B cells in systemic sclerosis.Biologics : targets & therapy · 2008Article
- Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.Clinical reviews in allergy & immunology · 2008Review
- Consensus statement on the use of rituximab in patients with rheumatoid arthritis.Annals of the rheumatic diseases · 2007Article
- Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.Annals of the rheumatic diseases · 2005Article
- SLE - Rituximab in lupus.Arthritis research & therapy · 2003Article
- B cells as a therapeutic target in autoimmune disease.Arthritis research & therapy · 2003Article
- Therapeutic antibodies for human diseases at the dawn of the twenty-first century.Nature reviews. Drug discovery · 2003Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.